TipRanks
Advertisement
Advertisement
AtriCure price target lowered to $50 from $55 at UBS
PremiumThe FlyAtriCure price target lowered to $50 from $55 at UBS
2M ago
Atricure Still Faces Broad, Evolving Risks Despite No Material Changes in 2025 10-K Disclosures
Premium
Company Announcements
Atricure Still Faces Broad, Evolving Risks Despite No Material Changes in 2025 10-K Disclosures
2M ago
Atricure Earnings Call Signals Profitable Growth Momentum
Premium
Company Announcements
Atricure Earnings Call Signals Profitable Growth Momentum
2M ago
FDA posts approval of Edwards left atrial appendage system
PremiumThe FlyFDA posts approval of Edwards left atrial appendage system
3M ago
AI Models Turn More Positive on AtriCure as Fundamentals Strengthen
Premium
AI Analyst Ratings
AI Models Turn More Positive on AtriCure as Fundamentals Strengthen
3M ago
AtriCure management to meet with Piper Sandler
Premium
The Fly
AtriCure management to meet with Piper Sandler
3M ago
AtriCure Earnings Call Highlights Profitable Growth Pivot
PremiumCompany AnnouncementsAtriCure Earnings Call Highlights Profitable Growth Pivot
4M ago
AtriCure reports Q1 EPS ,0c consensus (6c)
Premium
The Fly
AtriCure reports Q1 EPS ,0c consensus (6c)
4M ago
Is ATRC a Buy, Before Earnings?
Premium
Pre-Earnings
Is ATRC a Buy, Before Earnings?
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100